Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity

Journal: Journal of Clinical Investigation

Published: 2020-11-24

DOI: 10.1172/jci137001

Affiliations: 5

Authors: 11

Go to article
Institutions Share
Beckman Research Institute, City of Hope, United States of America (USA) 0.73
City of Hope, United States of America (USA) 0.27

Return